Pain Medication and Pain Intensity Following Hip Fractures-Analyses Based on the ProFem Cohort Study.

Kathrin JobskiMichaela RitschelKatja Pöggel-KrämerDaniela AnheierBurkhard HaastertVeronika GontscharukWerner ArendMarion BaltesAstrid StephanGabriele MeyerBirgit KlüppelholzJoachim WindolfSimon ThelenCarina JaekelSilke AndrichAndrea IcksFalk Hoffmann

Published in: Pharmacoepidemiology and drug safety (2024)

As a substantial number of patients reports high intensity pain about 3 months following a PFF, the large proportion of those receiving no or only PRN pain medication raises questions regarding the appropriateness of the therapy. The overall low utilization of the BMP indicates potential for improvement.

Keyphrases

high intensity
chronic pain
pain management
neuropathic pain
end stage renal disease
healthcare
resistance training
chronic kidney disease
stem cells
spinal cord injury
risk assessment
climate change
bone marrow
total hip arthroplasty
postoperative pain
drug induced